Olanzapine Extended-Release Injection and Omalizumab Subcutaneous
Determining the interaction of Olanzapine Extended-Release Injection and Omalizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: olanzapine
Brand name: Zyprexa, Zyprexa Zydis, Zyprexa Intramuscular, Zyprexa Relprevv
Synonyms: Olanzapine, OLANZapine
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Olanzapine Extended-Release Injection-Ombitasvir, Paritaprevir, and Ritonavir
- Olanzapine Extended-Release Injection-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Olanzapine Extended-Release Injection-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Olanzapine Extended-Release Injection-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Olanzapine Extended-Release Injection-Omeclamox-Pak
- Olanzapine Extended-Release Injection-Omega-3 Fatty Acid Capsules
- Omalizumab Subcutaneous-Olanzapine injection
- Omalizumab Subcutaneous-Olanzapine Intramuscular
- Omalizumab Subcutaneous-Olanzapine Orally Disintegrating Tablets
- Omalizumab Subcutaneous-Olanzapine Tablets
- Omalizumab Subcutaneous-Olanzapine, Olanzapine Pamoate
- Omalizumab Subcutaneous-Olaparib